Prosecution Insights
Last updated: October 25, 2026

Medovate Limited

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Medovate Limited operates in the Medical Devices & Mechanical Engineering technology area with a targeted patenting strategy. The portfolio currently includes 1 pending office action located in 1 distinct art unit. This concentration suggests a narrow scope for the entity's current prosecution activity.

The prosecution is handled by 1 distinct examiner, RAUBENSTRAW, TYLER ALLEN, who is also the busiest examiner with 1 busiest examiner pending action. Because the entire pending docket is managed by one person, the prosecution path is very streamlined. This structure places high importance on the specific feedback and standards of this single examiner.

Practitioners should note that the lack of examiner variety necessitates a highly targeted response strategy. Because there are no other active cases, the specific feedback from this examiner is the only guidance available for the current portfolio. Success in this environment depends on a clear and persuasive communication with the assigned art unit.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RAUBENSTRAW, TYLER ALLEN 1 71.2% +30.6%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
16962631 SAFETY WARNING SYSTEM RAUBENSTRAW, TYLER ALLEN —

Top Art Units

Art UnitApps
3785 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
16962631 SAFETY WARNING SYSTEM RAUBENSTRAW, TYLER ALLEN 3785 §103 Non-Final OA — Pending Jul 16, 2020

Managing Medovate Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Medovate Limited have?

Medovate Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Medovate Limited applications?

Tyler Allen Raubenstraw has the most, with 1 of Medovate Limited's pending office actions.

What technology area are Medovate Limited's patent applications in?

Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month